As part of our commitment to your digital security and privacy, UL is transitioning to a new email policy. Please confirm if you wish to continue receiving emails from UL containing best practices, education, industry research, news, updates and promotions related to UL products and services. Thank you!
Postmarket Reporting of Adverse Drug Experiences
Identify the process for reporting postmarketing adverse drug experiences to FDA.
After this course learners will be able to identify the process for reporting postmarketing adverse drug experiences to fda.